Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1343 studies found for:    Open Studies | "Lung Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
2 Unknown  Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
3 Not yet recruiting Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma
Conditions: Lung Cancer;   Squamous Cell Carcinoma of the Lung;   Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung
Interventions: Drug: Intravenous Cisplatin & etoposide;   Drug: Intravenous Cisplatin & etoposide along with oral cyclophosphamide
4 Recruiting Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Conditions: Small Cell Lung Carcinoma;   Non Small Cell Lung Carcinoma;   Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib;   Drug: Irinotecan
5 Recruiting TF2- Small Cell Lung Cancer Radio Immunotherapy
Conditions: Small Cell Lung Cancer;   CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Drug: Antibody TF2;   Radiation: IMP-288-Lutetium;   Radiation: IMP-288-Indium
6 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
7 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
8 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
9 Recruiting Biomarkers for Diagnosis of Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasm
Intervention:
10 Not yet recruiting Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
Condition: Lung Neoplasms
Intervention: Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy
11 Unknown  Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: Treated by endostar combined with docetaxel and cisplatin;   Drug: Treated by docetaxel and cisplatin
12 Unknown  Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
Conditions: Lung Neoplasms;   Neoplasm Metastasis
Intervention: Drug: Cisplatin, Thiosulfate
13 Recruiting Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
Condition: Lung Neoplasms
Intervention:
14 Not yet recruiting Virtual Intervention for Lung Cancer
Condition: Lung Neoplasms
Interventions: Behavioral: Virtual experience;   Behavioral: Videos
15 Recruiting Correlation Research of Thioredoxin Reductase in Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Benign Neoplasm of Lung
Intervention:
16 Recruiting Specimen Banking From Patients With Lung Cancer
Condition: Lung Neoplasms
Intervention:
17 Not yet recruiting A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
Conditions: Lung Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases
Interventions: Device: MIMIG System;   Drug: Indocyanine Green (ICG)
18 Recruiting DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
19 Recruiting Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer
Condition: Lung Neoplasms
Intervention:
20 Recruiting Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
Condition: Non Small Cell Lung Carcinoma
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years